PROS1 and viral infectious disease: Specific sulfated polysaccharides, including fucoidans and heparin, can bind tightly to the S protein of SARS-CoV-2 in vitro, which suggests that they can act as decoys to interfere with S-protein binding to the heparan-sulfate co-receptor in host tissues, inhibiting viral infection [9].